Martin Shkreli, Twitter And Moving Markets In 140 Characters Or Less |
| December 04, 2015 | December 2015 Bond Updates |
|
November 20 is a date that will live in infamy for investors who were short a tiny pharmaceutical company named KaloBios Pharmaceuticals. And it started with a tweet.
Martin Shkreli, the Founder and Chief Executive Officer of Turing Pharmaceuticals AG, has acquired 70% of its outstanding shares $KBIO
— Martin Shkreli (@MartinShkreli) November 20, 2015 |
| View more at: http://www.forbes.com/sites/corinnejurney/2015/12/03/martin-shkreli-twitter-and-moving-markets-in-140-characters-or-less/ |
| Related News |